Translating these findings to therapy, we validate that combining chemotherapy with WAT browning inhibitors (targeting CRC-adipose metabolic crosstalk) or FFA uptake blockers (cutting off tumour energy supply) boosts anti-cancer efficacy-establishing a mechanism-based framework for CRC patients with aberrant MIIP expression. This evidence concerns the gene MIIP and cancer.